Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,588 | 647 | 99.2% |
| Education | $128.75 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,964 | 98 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,634 | 52 | $0 (2022) |
| ABBVIE INC. | $1,343 | 54 | $0 (2024) |
| Alkermes, Inc. | $1,338 | 41 | $0 (2024) |
| Allergan, Inc. | $1,261 | 49 | $0 (2020) |
| Lundbeck LLC | $1,186 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,024 | 25 | $0 (2024) |
| Bausch Health US, LLC | $1,003 | 55 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $909.59 | 49 | $0 (2024) |
| Axsome Therapeutics, Inc. | $750.44 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,733 | 63 | Otsuka America Pharmaceutical, Inc. ($286.07) |
| 2023 | $1,786 | 73 | Axsome Therapeutics, Inc. ($496.70) |
| 2022 | $2,464 | 90 | ABBVIE INC. ($407.15) |
| 2021 | $2,096 | 93 | AbbVie Inc. ($463.04) |
| 2020 | $1,449 | 84 | Otsuka America Pharmaceutical, Inc. ($214.08) |
| 2019 | $3,232 | 97 | Sunovion Pharmaceuticals Inc. ($748.90) |
| 2018 | $1,735 | 91 | Sunovion Pharmaceuticals Inc. ($359.39) |
| 2017 | $1,222 | 63 | Allergan Inc. ($412.75) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $102.31 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.75 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $7.22 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Education | In-kind items and services | $7.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Education | In-kind items and services | $7.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: PSYCHIATRY | ||||||
| 08/08/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: Neuroscience | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 149 | $53,450 | $17,565 |
| 2022 | 2 | 54 | 128 | $34,725 | $13,835 |
| 2021 | 2 | 76 | 208 | $53,000 | $22,146 |
| 2020 | 7 | 152 | 637 | $334,300 | $63,968 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 95 | $41,250 | $13,737 | 33.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 20 | 54 | $12,200 | $3,828 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 64 | $21,175 | $9,104 | 43.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 27 | 64 | $13,550 | $4,731 | 34.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 38 | 104 | $32,100 | $14,332 | 44.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 38 | 104 | $20,900 | $7,814 | 37.4% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 13 | 297 | $207,900 | $28,224 | 13.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 41 | 120 | $35,150 | $13,087 | 37.2% |
| 90869 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 13 | 56 | $54,600 | $8,821 | 16.2% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 41 | 120 | $24,050 | $8,705 | 36.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 16 | 16 | $5,600 | $2,307 | 41.2% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 16 | 16 | $4,000 | $1,609 | 40.2% |
| 96130 | Psychological testing evaluation by qualified health care professional, first 60 minutes | Office | 2020 | 12 | 12 | $3,000 | $1,216 | 40.5% |
About Dr. Dmitriy Sivtsov, MD
Dr. Dmitriy Sivtsov, MD is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467553958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dmitriy Sivtsov, MD has received a total of $15,717 in payments from pharmaceutical and medical device companies, with $1,733 received in 2024. These payments were reported across 654 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($15,588).
As a Medicare-enrolled provider, Sivtsov has provided services to 322 Medicare beneficiaries, totaling 1,122 services with total Medicare billing of $117,514. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location San Diego, CA
- Active Since 09/26/2006
- Last Updated 03/13/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467553958
Products in Payments
- VRAYLAR (Drug) $2,462
- REXULTI (Drug) $2,090
- LATUDA (Drug) $1,634
- SPRAVATO (Drug) $956.37
- TRINTELLIX (Drug) $951.96
- APLENZIN (Drug) $930.05
- ARISTADA (Drug) $877.02
- Auvelity (Drug) $750.44
- CAPLYTA (Drug) $610.54
- ABILIFY MAINTENA (Drug) $400.53
- BELSOMRA (Drug) $301.91
- AUSTEDO (Drug) $291.50
- Dayvigo (Drug) $252.68
- BRINTELLIX (Drug) $242.66
- LYBALVI (Drug) $242.43
- MYDAYIS (Drug) $231.07
- INGREZZA (Drug) $210.51
- ABILIFY MYCITE (Drug) $186.38
- Trintellix (Drug) $184.94
- QUVIVIQ (Drug) $179.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Diego
Dr. Jonathan Meyer, M.d, M.D
Psychiatry — Payments: $2.0M
Dr. Sanjai Rao, M.d, M.D
Psychiatry — Payments: $633,149
Dr. Murray Stein, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $115,110
Dr. Mukesh Sanghadia, M.d., Mrcpsych(Uk), M.D., MRCPSYCH(UK)
Psychiatry — Payments: $82,626
Dr. Neil Richtand, M.d, M.D
Psychiatry — Payments: $76,458
Clark Smith, Md, MD
Psychiatry — Payments: $72,261